Literature DB >> 14994772

Mucosal changes in rhinitis medicamentosa.

Chun-Yu Lin1, Po-Hsu Cheng, Sheen-Yie Fang.   

Abstract

To evaluate the nasal mucosal changes in rhinitis medicamentosa (RM), especially those related to goblet cells and subepithelial glands, we studied specimens of the inferior turbinate mucosa from 8 patients with RM, 8 patients with chronic hypertrophic rhinitis (CHR), and 5 patients with normal nasal mucosa. All specimens were assessed by electron microscopy and immunohistochemical study. Under a scanning electron microscope, hyperplasia of goblet cells was most prominent in the RM group, and an increased number of gland openings was evident in the RM and CHR groups. In addition, the immunoreactivity of epidermal growth factor receptor staining was strongest in the hyperplastic epithelium of the RM group. According to our results, it is feasible that the mucosa of patients with RM is in a chronic inflammatory, hypersecretory state. Degenerative changes in the secretory elements may cause impairment of mucociliary transport and may be responsible for the nasal obstruction and posterior nasal drip in RM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14994772     DOI: 10.1177/000348940411300213

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  10 in total

1.  Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.

Authors:  Behram Cam; Murat Sari; Ahmet Midi; Ozgül Gergin
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-29       Impact factor: 2.503

2.  The importance of vascular epithelial growth factor (VEGF) and inducible nitric oxide synthase (INOS) in rhinitis medicamentosa pathogenesis: An experimental rat model study.

Authors:  Alev Cumbul; Fuat Bulut
Journal:  Histol Histopathol       Date:  2021-11-29       Impact factor: 2.303

3.  Mucosal changes in chronic hypertrophic rhinitis after surgical turbinate reduction.

Authors:  George Gindros; Ilias Kantas; Dimitrios G Balatsouras; Dimitris Kandiloros; Anastasios K Manthos; Aikaterini Kaidoglou
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-30       Impact factor: 2.503

4.  Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.

Authors:  Achim G Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

5.  Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor.

Authors:  Gustavo Nino; Orkun Baloglu; Maria J Gutierrez; Michael Schwartz
Journal:  Int J Otolaryngol       Date:  2011-12-19

Review 6.  Rhinitis Subtypes, Endotypes, and Definitions.

Authors:  Nikolaos G Papadopoulos; George V Guibas
Journal:  Immunol Allergy Clin North Am       Date:  2016-02-28       Impact factor: 3.479

7.  Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.

Authors:  James Fowler; Christopher J Chin; Emad Massoud
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-12-09

8.  Rhinosinusitis in children.

Authors:  Sukhbir K Shahid
Journal:  ISRN Otolaryngol       Date:  2012-12-05

9.  Effects and safety of intranasal phototherapy for allergic rhinitis: Study protocol for a single-center, randomized, parallel (acupuncture-controlled), open-label, investigator-initiated, pilot study.

Authors:  Jeongin Kang; Goeun Lee; Miju Son; Youngeun Kim; Namhun Heo; Donghyo Lee
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

10.  Effects and safety of intranasal phototherapy for allergic rhinitis: Study protocol for a single-center, randomized, double-blind, parallel, placebo-controlled, investigator-initiated, pilot study.

Authors:  Jeongin Kang; Goeun Lee; Jeonghun Kim; Youngeun Kim; Sunju Park; Donghyo Lee
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.